Clinical Trial Update: Efficacy and Safety of Rifaximin With NAC in IBS-D [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating rifaximin with N-acetylcysteine for irritable bowel syndrome with diarrhea (IBS-D); results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Rifaximin (rifaximin)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-28